Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02388191 · ClinicalTrials.gov registry record · NA
Naproxen for Pain Control With Intrauterine Device Insertion
A NA study, sponsored by Planned Parenthood League of Massachusetts.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT02388191 is a NA study that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 119 participants.
The verdict
NCT02388191, a NA study, has completed, sponsored by Planned Parenthood League of Massachusetts.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
The purpose of this study is: 1. To evaluate whether 550 mg of naproxen sodium reduces pain scores with IUD insertion on a 0-10cm visual analogue scale compared to placebo (primary outcome). 2. To evaluate whether 550 mg of naproxen sodium reduces pain scores with tenaculum placement, uterine sounding and post-procedurally on a 0-10 cm visual analog scale compared to placebo (secondary outcomes). 3. To establish if prophylactic naproxen sodium is acceptable for routine use prior to IUD insertion. Hypothesis: The administration of naproxen sodium, 550mg orally, 1 hour prior to IUD insertion will lead to a reduction in pain scores associated with IUD insertion compared to placebo.
Interventions
- OTHER Placebo tablet
- DRUG Naproxen sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02388191
The ClinicalTrials.gov registry entry for NCT02388191 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo tablet is the first listed.
NCT02388191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02388191 about?
NCT02388191 is a clinical study titled "Naproxen for Pain Control With Intrauterine Device Insertion". The purpose of this study is: 1. To evaluate whether 550 mg of naproxen sodium reduces pain scores with IUD insertion on a 0-10cm visual analogue scale compared to placebo (primary outcome). 2. To evaluate whether 550 mg of naproxen sodium reduces pain scores with tenaculum placement, uterine sound...
What is the current status of trial NCT02388191?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2015-04. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02388191?
The interventions under investigation include: Placebo tablet (OTHER), Naproxen sodium (DRUG).
Who is sponsoring clinical trial NCT02388191?
This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.